Option Care Health, Inc. (OPCH) P/E Ratio History
Historical price-to-earnings valuation from 1998 to 2026
Loading P/E history...
OPCH Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Option Care Health, Inc. (OPCH) trades at a price-to-earnings ratio of 16.3x, with a stock price of $20.75 and trailing twelve-month earnings per share of $1.30.
The current P/E is 47% below its 5-year average of 30.8x. Over the past five years, OPCH's P/E has ranged from a low of 19.0x to a high of 79.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, OPCH trades at a 27% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, OPCH trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OPCH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OPCH P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 42.5 | 4.23 | +18% | |
| $2B | 27.5Lowest | - | +53% | |
| $111B | 62.8 | - | -62% | |
| $92B | 29.2 | 0.75Best | +15% | |
| $44B | 28.7 | - | +87%Best | |
| $50B | 32.1 | - | +6% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
OPCH Historical P/E Data (1998–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $26.92 | $1.29 | 20.9x | -59% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $31.86 | $1.28 | 24.9x | -51% |
| FY2025 Q3 | $27.76 | $1.26 | 22.0x | -57% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $32.48 | $1.25 | 26.0x | -49% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $34.95 | $1.24 | 28.2x | -45% |
| FY2024 Q4 | $23.20 | $1.22 | 19.0x | -63% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $31.30 | $1.19 | 26.3x | -49% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $27.70 | $1.19 | 23.3x | -54% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $33.54 | $1.52 | 22.1x | -57% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $33.69 | $1.47 | 22.9x | -55% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $32.35 | $1.41 | 22.9x | -55% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $32.49 | $1.31 | 24.8x | -51% |
Average P/E for displayed period: 51.1x
See OPCH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OPCH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OPCH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOPCH — Frequently Asked Questions
Quick answers to the most common questions about buying OPCH stock.
Is OPCH stock overvalued or undervalued?
OPCH trades at 16.3x P/E, below its 5-year average of 30.8x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does OPCH's valuation compare to peers?
Option Care Health, Inc. P/E of 16.3x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is OPCH's PEG ratio?
OPCH PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1998-2026.